|
Gayatri Ravikumar describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo Vascular endothelial growth factor in ovarian serous cancers Ovarian serous carcinomas (OSCs) express vascular endothelial growth factor (VEGF) in about 80% of cases, although their effect on tumour proliferation was not confirmed. Though the proliferative activity in OSCs is influenced by many growth factors, VEGF increases the intratumoral micro vessel density, thereby having an indirect effect on tumour proliferation. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Department of Pathology,St.John's Medical College., Bangalore, Karnataka, India  Authors' Report Crónica del Autor Bibliographic references Referencias bibliográficas Bajpai J. Vascular endothelial growth factor as an angiogenic switch in ovarian carcinoma. South Asian J Cancer 2(3):203, 2013. Boocock CA, Jones DSC, Sharkey AM, et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87(7):506-516, 1995. Brustmann H, Naude S. Vascular Endothelial Growth Factor expression in serous ovarian carcinomas: Relationship with High Mitotic Activity and High FIGO Stage. Gynecol Oncol 84:47-52, 2002. Dordevic G, Ilijaš KM, Sinožic E, et al. Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors. Croat Med J 49:608-617, 2008. Fan F, Wey JS, McCarty MF, et al. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24:2647-2653, 2005. Garzetti GG, Ciavattini A, Lucarini G, et al. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: Relationship with MIB1 immunostaining. Gynecol Oncol 73(3):396-401, 1999. Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL. Expression of Vascular Endothelial Growth Factor Receptors on Tumor Cells in Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surgery 129:882-888, 2003. Masood R, Cai J, ZhengTD, Smith L, Hinton DR, Gill PS. VEGF is an autocrine growth factor for VEGF receptor positive human tumors. Blood 98:1904-1913, 2001. Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour proliferation in human epidermoid lung carcinoma. Br J Cancer 73:931-934, 1996. Mattern J, Stammler G, Koomagi R, Wallwiener D, Kaufmann M, Volm M. Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res 17(1B):621-624, 1997. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial cell -A, -C and -D in breast cancer and their relationship angio- and lymphangiogenesis. Br J Cancer 96:1092-1100, 2007. Paley PJ, Staskus KA, Gebhard K, et al .Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80: 98-106, 1997. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Vascular Endothelial Growth Factor Expression in Ovarian Serous Carcinomas and Its Effect on Tumor Proliferation Author / Autor Gayatri Ravikumar1, Julian Crasta A2 2 Dr., St.john's Medical College, Additional Professor Access to the original source South Asian Journal of Cancer Article URL: / URL del artículo: URL of Abstract page in Medline: / URL del abstract en Medline: http://www.ncbi.nlm.nih.gov/pubmed/24455566 siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
||||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
